CONTACT ME


  • Kimberly A. Kralowec
    Schubert Jonckheer Kolbe & Kralowec LLP
    Three Embarcadero Center,
    Suite 1650
    San Francisco, CA 94111
    Telephone: (415) 788-4220
    Facsimile: (415) 788-0161
    Email: uclpractitioner@gmail.com

July 2009

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Disclaimer


  • Nothing in this blog constitutes legal advice. If you need legal advice, consult an attorney in your jurisdiction. To read this blog's complete disclaimer, click here.


  • The UCL Practitioner
    © 2003-2009
    by Kimberly A. Kralowec
    All rights reserved.


  • Enter your email address:

    Delivered by FeedBurner




  • Header design by Webmotion
    Photos by Jack Gescheidt
    Powered by TypePad

« Are you in Los Angeles? And are you hiring? | Main | "Five Oral Argument Tips — For Judges" »

Monday, November 24, 2008

Statement of issues on review in Clayworth v. Pfizer, Inc.

The Supreme Court has posted its statement of issues on review in Clayworth v. Pfizer, Inc., no. S166435. The UCL-related issues are particularly interesting:

(1) When plaintiffs pay overcharges on goods or services as a result of the anticompetitive conduct of defendant sellers but recover the overcharges through increased prices at which the goods or services are sold to end users, may defendants assert a "pass-on" defense and argue that plaintiffs were not injured because they did not suffer financial loss as a result of the anticompetitive conduct? (2) Is restitution available under the Unfair Competition Law (Bus. & Prof. Code, 17200 et seq.) to plaintiffs who recovered from third persons the overcharges paid to defendants? (3) When plaintiffs recover from third persons the overcharges paid to defendants, have they suffered actual injury and lost money or property for purposes of establishing standing under the Unfair Competition Law, as amended by Proposition 64?

I've added Clayworth to my list of pending California Supreme Court cases of interest to UCL and class action practitioners. I also added Brinker to that list.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8345172b069e20105361139d4970b

Listed below are links to weblogs that reference Statement of issues on review in Clayworth v. Pfizer, Inc.:

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Research


California Law Blogs